If you want to find the best deals in Amazon’s Spring Deal Days sale, you've come to the right place. There are savings to be snapped up on top tech and beautyproducts as well as household appliances ...

A long-running study of South Asians investigates why they are more prone to diabetes and heart disease, highlighting the need for alternate screening methods.

Navigating Midlife Ever noticed how belly fat seems to become a loyal companion once you hit a certain age? Blame it on the hormones! As we … ...

Not all body fat is created equal.

Phase 3 study designed with total hip BMD primary endpoint assessed at 12 months, rather than at 24 months. EB613 single ...

TG Therapeutics reported $594M in 2025 U.S. BRIUMVI sales, a 90% YoY increase, and guides for $825–$850M in 2026. Click here to read why TGTX is a Strong Buy.

A new Season of Beat the Couch is upon us and so life has been a little crazy. The past 24 hours has seen a flurry of ...

Raleigh-based Slate Medicines just pulled in a hefty $130 million Series A, a war chest the startup says will fuel development of SLTE‑1009, an in‑licensed anti‑PACAP monoclonal antibody aimed at ...

I wholeheartedly believe in the adage “when you look good, you feel good.” And if I’m hitting the wall in a race or dragging my feet to start a dreaded hill-sprints run, I’m really looking for ...

If approved, a subcutaneous formulation of anifrolumab would allow patients the ability to self-administer the medication outside of a hospital or clinic setting. The Food and Drug Administration (FDA ...

A Prescription Drug User Fee Act target date of May 24, 2026 has been set for the application. Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody directed against aggregated soluble ...

A Prescription Drug User Fee Act target date of May 24, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License ...